|
Recent Developments |
|
07-DEC-12
Pfizer`s board of directors (BoD) has approves the sale of its wholly owned subsidiary Pfizer Animal Pharma (PAPPA) to Pfizer Animal Health India (PAHIL).
13-AUG-12
Pfizer, the research-based pharmaceutical company, today reported increase of 7.94 times in a net profit to Rs 3,288.8 million for the quarter ended June 30, 2012 as compared to Rs 414.2 million in the same period last year.
21-MAY-12
Pfizer reported a 23.82% fall in ne... More.. |
| Business Profile |
Future Plans |
|
|
|
One To One
| Face To Face | | We would like to grow above the market and have a whole lot of strategies. We are looking at alliances, brands, lucrative products, line extensions, new delivery systems Kewal Handa ,finance director |
|
|
Recent news
|
|
|
| Period ending (months) | 31-Dec-2012(9) | 31-Mar-2012 (12) | 30-Nov-2010(12) | | Net sales | 6957.70 | 10173.00 | 8763.90 | | Other Income | 741.20 | 905.60 | 732.10 | | Total Income | 7698.90 | 11078.60 | 9496.00 | | Cost of goods sold | 6342.60 | 8966.20 | 7401.10 | | OPBDIT | 1356.30 | 2112.40 | 2094.90 | | PAT | 4450.40 | 1846.10 | 1632.00 | | Gross Block | - | - | - | | Equity capital | 298.40 | 298.40 | 298.40 | | EPS (Rs.) | - | 61.87 | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 17.32 - 26.45 | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 17.6 | 19.1 | 22.1 | | Net margin (% of OI) | 57.8 | 16.7 | 17.2 |
|
|
Detailed Financials
|
|
|
|
|
Snapshot
